2026年02月02日 星期一

> SARS-CoV 滴鼻感染BALB/c小鼠模型

中文名称Chinese name SARS-CoV 滴鼻感染BALB/c小鼠模型
编号Model number
英文名称English name SARS-CoV intranasally infection of BALB/c mouse model
物种Species name 小鼠
品系Strain name BALB/c小鼠
人类疾病Human diseases SARS
传染性Infectivity
微生物Microorganism
类别Category SARS-CoV感染动物模型 
造模因素Modeling factors
制作方法Making method BALB/c mice (female, 6-week-old (Japan SLC, Shizuoka, Japan); n = 6–7; total, 25) were immunized subcutaneously twice at 2 week intervals with 1 µg, 0.5 µg, 0.1 µg, or 0.05 µg doses of the protein in 100 µL PBS.Approximately 3 weeks after the second immunization, mice were anesthetized via intraperitoneal injection of a mixture of 1.0 mg ketamine (Daiichi Sankyo Company, Tokyo, Japan) and 0.02 mg xylazine (Byer Japan, Osaka, Japan) (0.08 ml/10 g of body weight). These mice were then inoculated intranasally with SARS-CoV (106 TCID50 in 30 µl of 2% FBS-MEM).
生物学特征Biological characteristics
医学用途Medical use 用于SARS-CoV致病机制研究、疫苗和药物评估。 
临床表现Clinical manifestation
病理表现Pathology
发病天数Days of onset
发病过程Pathogenesis process
临床诊断Clinical diagnosis 血管周围水肿,炎症细胞浸润
评价模型成功的指标Indicators for evaluating model success
保藏单位Preservation unit 日本国立传染病研究所@@https://www.niid.go.jp/
参考文献Reference Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.,PMID:31692019,DOI:10.1111/1348-0421.12754
录入/更新时间Date 2021.7.20
备注Remarks
返回顶部